Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): A Swedish nationwide study based on patient reports

Lupus

Volumn 22, Issue 8, 2013, Pages 793-801

  Bexelius, C ^a   Wachtmeister, K ^b   Skare, P ^b   Jonsson L ^a   Vollenhoven, R Van ^c  

^a OptumInsight   (Sweden)

^b GLAXOSMITHKLINE   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cost of illness; disease severity; fatigue; health related quality of life; Systemic lupus erythematous

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COST OF ILLNESS; DISEASE ACTIVITY; DRUG MEGADOSE; FATIGUE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SWEDEN; SYSTEMIC LUPUS ACTIVITY QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS;

COST OF ILLNESS; DISEASE SEVERITY; FATIGUE; HEALTH-RELATED QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOUS;

ADULT; AGED; COHORT STUDIES; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; GLUCOCORTICOIDS; HEALTH CARE COSTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SWEDEN;

EID: 84879720841     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313491849     Document Type: Article

References (26)

1. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: An update. Ann Acad Med Singapore. 2007 ; 36: 115-122
2. Li T, Carls GS, Panopalis P, Wang S, Gibson TB, Goetzel RZ. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large Medicaid population. Arthritis Rheum. 2009 ; 61: 755-763
3. Zhu TY, Tam LS, Li EK. Cost of illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2011 ; 63: 751-760
4. Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database. Clin Ther. 2009 ; 31: 2653-2664
5. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006 ; 15: 633-643
6. Zhu LW, Zhang T, Pan HF, Li XP, Ye DQ. BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus. Clin Rheumatol. 2010 ; 29: 1413-1417
7. Tamayo T, Fischer-Betz R, Beer S, Winkler-Rohlfing B, Schneider M. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: Long-term results (2001-2005) of patients in the German Lupus Erythematosus Self-Help Organisation (LULA Study). Lupus. 2010 ; 19: 1606-1613
8. Pettersson S, Möller S, Svenungsson E, Gunnarsson I, Welin Henriksson E. Women's experience of SLE-related fatigue: A focus group interview study. Rheumatology (Oxford). 2010 ; 49: 1935-1942
9. Cleanthous S, Tyagi M, Isenberg DA, Newman SP. What do we know about self-reported fatigue in systemic lupus erythematosus?. Lupus. 2012 ; 21: 465-476
10. Kiani AN, Petri M. Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep. 2010 ; 12: 250-258
11. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
12. Gift AG. Visual analogue scales: Measurement of subjective phenomena. Nurs Res. 1989 ; 38: 286-288
13. Banthia R, Malcarne VL, Roesch SC, et al. Correspondence between daily and weekly fatigue reports in breast cancer survivors. J Behav Med. 2006 ; 29: 269-279
14. Brunier G, Graydon J. A comparison of two methods of measuring fatigue in patients on chronic haemodialysis: Visual analogue vs Likert scale. Int J Nurs Stud. 1996 ; 33: 338-348
15. Karlson EW, Daltroy LH, Rivest C, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003 ; 12: 280-286
16. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 ; 46: 1121-1123
17. Burström K, Johannesson M, Rehnberg C. Deteriorating health status in Stockholm 1998-2002: Results from repeated population surveys using the EQ-5D. Qual Life Res. 2007 ; 16: 1547-1553
18. Zonana-Nacach A, Roseman JM, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. Lupus. 2000 ; 9: 101-109
19. Stockton KA, Kandiah DA, Paratz JD, Bennell KL. Fatigue, muscle strength and vitamin D status in women with systemic lupus erythematosus compared to healthy controls. Lupus. 2012 ; 21: 271-278
20. Panopalis P, Yazdany J, Gillis JZ, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 1788-1795
21. Clarke AE, Petri M, Manzi S, et al. The systemic lupus erythematosus Tri-nation Study: Absence of a link between health resource use and health outcome. Rheumatology (Oxford). 2004 ; 43: 1016-1024
22. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001 ; 40: 37-47
23. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006 ; 65: 1175-1183
24. Zhu TY, Tam LS, Lee VW, Lee KK, Li EK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1159-1167
25. Romero-Diaz J, Isenberg D, Ramsey-Goldman R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Res 2011; 63(Suppl 11): S37-S46.
26. Aggarwal R, Wilke CT, Pickard AS, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 1209-1216